Viewing nowCombinationJ-Forzide 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.

MFDS item code 201400003 · Approved 2014.01.02 · Insurance code 645404250
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, this medication is used to aid in blood pressure control when sufficient control is not achieved with monotherapy of amlodipine or valsartan. This medication helps lower blood pressure by dilating blood vessels and aids in reducing the risk of complications caused by hypertension. It is effective for ongoing blood pressure management and plays an important role in maintaining cardiovascular health. Therefore, it is well utilized in the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients: Use of this medicine is not recommended in patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients who are allergic to its components or similar drugs, as well as in women who are pregnant or nursing, and in patients with severe renal or liver disease. Patients with low sodium or fluid levels in the body may experience hypotension, hence it is important to carefully assess their condition before administration and monitor blood pressure closely during treatment. Patients with high potassium levels should use caution if taking this medication alongside drugs that may increase potassium, and should have their potassium levels frequently checked. Patients with issues related to renal arteries or those who have undergone kidney transplantation should be carefully monitored as this medication may affect renal function. This medication may cause a serious allergic reaction known as angioedema; therefore, if swelling of the face or neck occurs, or if difficulty breathing is experienced, it should be discontinued immediately and medical advice should be sought. Patients with heart failure or those who have had a myocardial infarction may experience worsening renal function or hypotension with this medication, thus regular renal function tests are necessary. This medication may cause dizziness or fatigue when driving or operating machinery, so caution is advised. Interactions may occur when taken with specific other medications, so patients should inform their healthcare providers of any other medications they are taking. Elderly patients are recommended to take the same dosage as adults but should take care based on their physical condition. Overdosage may result in severe hypotension or cardiac problems, so it is crucial to adhere strictly to the prescribed dosage and seek medical attention if any abnormal symptoms appear. This medication is not recommended for patients under 18 years of age as its safety and efficacy have not been sufficiently established.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasms, weakness, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, generalized edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, acute renal failure, renal damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste abnormalities, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, sensory impairment, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture and must be stored in a tightly sealed container. It is important to keep the storage temperature between 1 to 30 degrees Celsius at room temperature.
Dark yellow rectangular film-coated tablet
28 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.